Sultana A, Banu L, Hossain M, Azmin N, Nila N, Sinha S
Viruses. 2025; 17(2).
PMID: 40006937
PMC: 11860708.
DOI: 10.3390/v17020182.
Edwards C, Karunakaran K, Garcia E, Beutler N, Gagne M, Golden N
PLoS Pathog. 2025; 21(1):e1012456.
PMID: 39847599
PMC: 11793774.
DOI: 10.1371/journal.ppat.1012456.
Rodriguez-Horta E, Strahan J, Dinner A, Barton J
bioRxiv. 2024; .
PMID: 39416020
PMC: 11482859.
DOI: 10.1101/2024.10.06.616878.
Dearlove B, Fries A, Epsi N, Richard S, Ganesan A, Huprikar N
Virus Evol. 2024; 10(1):veae071.
PMID: 39386074
PMC: 11463026.
DOI: 10.1093/ve/veae071.
Li J, Chen Y, Ye H, Tang Q, Wang C, Zhou Q
BMC Infect Dis. 2024; 24(1):794.
PMID: 39112970
PMC: 11305062.
DOI: 10.1186/s12879-024-09702-5.
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.
Edwards C, Karunakaran K, Garcia E, Beutler N, Gagne M, Golden N
bioRxiv. 2024; .
PMID: 39109178
PMC: 11302620.
DOI: 10.1101/2024.07.30.605768.
A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management.
Chavda V, Yadav D, Parmar H, Brahmbhatt R, Patel B, Madhwani K
Curr Top Med Chem. 2024; 24(21):1883-1916.
PMID: 38859776
DOI: 10.2174/0115680266296095240529114058.
Genomic surveillance and serological profile of SARS-CoV-2 variants circulating in Macaé and nearby cities, southeastern Brazil.
da Silva A, Silva C, de Sousa G, Coelho V, da Cunha L, Paes A
Front Microbiol. 2024; 15:1386271.
PMID: 38746751
PMC: 11091293.
DOI: 10.3389/fmicb.2024.1386271.
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis.
Chang E, Li H, Zheng W, Zhou L, Jia Y, Gu W
Appl Health Econ Health Policy. 2024; 22(4):457-470.
PMID: 38598091
DOI: 10.1007/s40258-024-00880-6.
The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations.
Cao B, Wang X, Yin W, Gao Z, Xia B
mBio. 2024; 15(5):e0318723.
PMID: 38530031
PMC: 11237538.
DOI: 10.1128/mbio.03187-23.
SARS-CoV-2 excretion kinetics in nasopharyngeal and stool samples from the pediatric population.
Khemiri H, Gdoura M, Halima S, Krichen H, Camma C, Lorusso A
Front Med (Lausanne). 2023; 10:1226207.
PMID: 38020093
PMC: 10643538.
DOI: 10.3389/fmed.2023.1226207.
Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences.
Salazar-Ardiles C, Asserella-Rebollo L, Cornejo C, Arias D, Vasquez-Munoz M, Toledo C
Mol Biol Rep. 2023; 50(12):10367-10382.
PMID: 37817022
DOI: 10.1007/s11033-023-08844-0.
Reinfection and Breakthrough Infection of SARS-CoV-2: An Emerging Challenge That Is Threatening Our World.
Gao L, Mu X, Jiao Y, Wang F
Infect Dis Immun. 2023; 2(1):29-33.
PMID: 37521155
PMC: 8772053.
DOI: 10.1097/ID9.0000000000000027.
Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles.
Zhang P, Falcone S, Tsybovsky Y, Singh M, Gopan V, Miao H
Proc Natl Acad Sci U S A. 2023; 120(29):e2305896120.
PMID: 37428933
PMC: 10629519.
DOI: 10.1073/pnas.2305896120.
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives.
Dong T, Wang M, Liu J, Ma P, Pang S, Liu W
Chem Sci. 2023; 14(23):6149-6206.
PMID: 37325147
PMC: 10266450.
DOI: 10.1039/d2sc06665c.
Tracking the first SARS-CoV-2 Omicron BA.5.1.3 outbreak in China.
Wang X, Zhu X, Lin Y, He L, Yang J, Wang C
Front Microbiol. 2023; 14:1183633.
PMID: 37275159
PMC: 10232789.
DOI: 10.3389/fmicb.2023.1183633.
Clinical and laboratory features of SARS-CoV-2 variants across multiple rounds of pandemic waves in hospitalized children in an Iranian referral hospital.
Mahmoudi S, Pourakbari B, Benvari S, Sadeghi R, Abdolsalehi M, Shahbabaie M
BMC Pediatr. 2023; 23(1):241.
PMID: 37193986
PMC: 10185932.
DOI: 10.1186/s12887-023-04042-w.
CoVnita, an end-to-end privacy-preserving framework for SARS-CoV-2 classification.
Sim J, Zhou W, Chan F, Annamalai M, Deng X, Tan B
Sci Rep. 2023; 13(1):7461.
PMID: 37156790
PMC: 10166033.
DOI: 10.1038/s41598-023-34535-8.
CoVizu: Rapid analysis and visualization of the global diversity of SARS-CoV-2 genomes.
Ferreira R, Wong E, Gugan G, Wade K, Liu M, Baena L
Virus Evol. 2023; 7(2):veab092.
PMID: 37124703
PMC: 10131274.
DOI: 10.1093/ve/veab092.
Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review.
Gutlapalli S, Ganipineni V, Danda S, Fabian D, Okorie I, Paramsothy J
Cureus. 2023; 15(3):e36809.
PMID: 37009363
PMC: 10060008.
DOI: 10.7759/cureus.36809.
